In conclusion, this research identifies SMIM1 and SEZ6L2 as important biomarkers of IDD associated with pyroptosis, which will help to unravel the development and pathogenesis of IDD and determine potential therapeutic targets. The gene discussed is SEZ6L2; the disease is intervertebral disk degenerative disorder.